SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid heightened anticipation for the Senate Banking Committee's markup session on the Digital Asset Market Clarity Act, which investors hope will provide much-needed regulatory certainty. Community members are split between optimistic bulls expecting institutional adoption and skeptical traders frustrated by the asset's persistent volatility and history of failing to sustain breakout rallies.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis is trending as the community scrutinizes the company's shift toward redomiciling to Delaware while navigating persistent tax headwinds and regulatory uncertainty surrounding federal rescheduling. Investors are actively debating the timing of potential tax relief and institutional support, weighing long-term sector growth against ongoing frustration over recent price volatility and unsuccessful efforts to secure adult-use ballot initiatives in Florida.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors digest a surge in institutional ownership, including significant stakes from major entities like Nvidia, fueling community debate over its pivot into AI infrastructure and optical networking. While short-term traders navigate volatility around key technical levels, long-term investors are actively discussing Nokias potential as a key player in the evolving AI-RAN and telecom landscape.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending as market participants analyze broader economic risks, including geopolitical instability and shifts in trade policy, while weighing the performance of broad-market index funds against sector-specific volatility. The community remains focused on long-term wealth creation strategies, with ongoing debate over the impact of geopolitical escalations on energy costs and the relative stability of passive index investing in a fractured global environment.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is currently trending as shareholders and analysts debate the impact of the FDA's second rejection of RP1, with community discourse divided between optimism for a potential regulatory reversal and concerns over the company's long-term financial viability. Traders are actively monitoring heightened volatility and high short interest, while discussions focus on the possibility of a leadership shift at the agency and the company's limited runway for future clinical development.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom shares are trending following a strategic cooperation agreement with activist investor Elliott Management, which includes the appointment of new board members and an expanded share buyback program. While some investors are optimistic about the company's long-term pivot toward broader biosensing and governance improvements, the community remains divided, with active discussions focusing on technical price action, skepticism over management's ability to drive growth, and contrasting views on competitive pressures in the continuous glucose monitoring space.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is currently drawing significant attention as investors navigate extreme short-term price volatility against a backdrop of strong long-term AI infrastructure demand and recent hyperscaler capacity expansions. While community sentiment remains largely bullish due to the company's fundamental shift toward higher-margin hardware solutions, many participants are actively debating the merits of day-trading the stock's wide swings versus holding through pullbacks for long-term growth.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy Inc. is trending as investors digest a massive earnings beat and strong production guidance, while the community actively debates whether the recent volatility represents a classic short squeeze or a long-term re-rating opportunity. Market participants are closely watching the company's domestic manufacturing strategy and scaling efforts as a key catalyst for potential future growth.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a strong momentum rally as investors position for the company's potential role in addressing AI data center power constraints, a narrative bolstered by the broader fuel-cell sector's recent strength. The community is actively discussing heavy institutional accumulation, intense options call volume, and the anticipation of signed contracts from its data center proposal pipeline.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is currently in the spotlight as investors weigh the impact of activist interest and significant capital return initiatives against ongoing concerns regarding management credibility and previous revenue performance. While the community remains divided over the company's long-term growth potential and recent operational headwinds, active discussions are focused on the firm's share buyback strength, institutional ownership levels, and the anticipated outcome of upcoming financial disclosures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


SPAR
Spartan Motors Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest SPAR News

SPARSpartan Motors Inc.